Generation Bio Co. (GBIO)

Generation Bio Co. Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-169.06	-126.61	-136.64	-119.15	-80.52	-61.32
Depreciation & Amortization	5.25	5.26	5.13	4.53	3.43	1.86
Share-Based Compensation	22.08	24.34	24.45	17.86	8.41	4.21
Other Operating Activities	84.97	44.26	4.61	4.94	-1.46	14.9
Operating Cash Flow	-56.77	-52.75	-102.45	-91.82	-70.14	-40.35
Capital Expenditures	-8.56	-7.4	-8.8	-5.85	-5.52	-19.91
Change in Investments	3.93	-2.3	-183.71	198.9	-199.68	67.89
Investing Cash Flow	-4.64	-9.7	-192.52	193.05	-205.2	47.99
Share Issuance / Repurchase	0.55	36.55	13.62	215.63	217.47	0.1
Other Financing Activities	-0.63	-0.73	-0.63	-0.96	105.63	-0.02
Financing Cash Flow	-0.08	35.82	12.99	214.67	323.1	0.08
Net Cash Flow	-61.48	-26.63	-281.97	315.9	47.76	7.72
Free Cash Flow	-65.33	-60.14	-111.25	-97.67	-75.66	-60.25
Free Cash Flow Margin	-655.68%	-1018.67%	-	-	-	-
Free Cash Flow Per Share	-0.98	-0.93	-1.91	-1.74	-2.78	-12.73

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).